| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 1102 |
| 1 | ADALIMUMAB | 840 |
| 2 | ALENDRONATE SODIUM | 827 |
| 3 | ETANERCEPT | 709 |
| 4 | PREDNISONE | 641 |
| 5 | METHOTREXATE SODIUM | 629 |
| 6 | METHOTREXATE | 588 |
| 7 | ACETAMINOPHEN | 537 |
| 8 | ASPIRIN | 487 |
| 9 | ASPIRIN 325 MG | 470 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 124 | 0.0447 |
| 1 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 149 | 0.0221 |
| 2 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 188 | 0.0210 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 159 | 0.0158 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 56 | 0.0156 |
| 5 | SODIUM MONOFLUOROPHOSPHATE | 5 | 0.0135 |
| 6 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 151 | 0.0132 |
| 7 | BUPRENORPHINE AND NALOXONE | 16 | 0.0128 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 297 | 0.0122 |
| 9 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 30 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1281 |
| 1 | Corticosteroid [EPC] | 1104 |
| 2 | RANK Ligand Inhibitor [EPC] | 1102 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 995 |
| 4 | Benzodiazepine [EPC] | 830 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 630 |
| 6 | Vitamin C [EPC] | 601 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 586 |
| 8 | Vitamin D [EPC] | 547 |
| 9 | Provitamin D2 Compound [EPC] | 537 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 537 | 0.0180 |
| 1 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 19 | 0.0092 |
| 3 | Opioid Antagonist [EPC] | 7 | 0.0073 |
| 4 | Adrenocorticotropic Hormone [EPC] | 6 | 0.0067 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 630 | 0.0057 |
| 6 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 328 | 0.0054 |
| 8 | RANK Ligand Inhibitor [EPC] | 1102 | 0.0054 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 43 | 0.0042 |